Evidence map›Paper›PMID 27913904›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2017

Association between brain structural anomalies, electroencephalogram and history of seizures in Mucopolysaccharidosis type II (Hunter syndrome).

Ramón Ernesto Jiménez-Arredondo, Aniel Jessica Leticia Brambila-Tapia, Francisco Miguel Mercado-Silva, Martha Ortiz-Aranda, Verónica Benites-Godinez, Graciela Olmos-García-de-Alba, Luis Eduardo Figuera

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Differences in MPS I and MPS II Disease Manifestations.International journal of molecular sciences · 2021
    Review
  2. News on the journal Neurological Sciences in 2017.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ramón Ernesto Jiménez-ArredondoHospital General No. 1, Instituto Mexicano del Seguro Social (IMSS), Tepic, Nayarit, Mexico.
Aniel Jessica Leticia Brambila-TapiaDepartamento de Psicología Básica, Universidad de Guadalajara (CUCS), Sierra Mojada #950, Colonia Independencia, 44340, Guadalajara, JAL, Mexico. anieljessica@hotmail.com.
Francisco Miguel Mercado-SilvaCentro Médico Nacional de Occidente (CMNO), Hospital de Pediatría, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, JAL, Mexico.
Martha Ortiz-ArandaCentro Médico Nacional de Occidente (CMNO), Hospital de Pediatría, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, JAL, Mexico.
Verónica Benites-GodinezHospital General No. 1, Instituto Mexicano del Seguro Social (IMSS), Tepic, Nayarit, Mexico.
Graciela Olmos-García-de-AlbaHospital Infantil de México, Federico Gómez, Ciudad de México, México, Mexico.
Luis Eduardo FigueraCentro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara, JAL, Mexico. luisfiguera@yahoo.com.
Mexican Social Security Institute · MXHospital Infantil de México Federico Gómez · MXUniversidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucopolysaccharidosis type II or Hunter syndrome (MPS II) is a genetic disease that can course with intellectual impairment and central nervous system (CNS) alterations. To date, no report has documented electroencephalogram (EEG) measures associated with CNS alterations, detected by imaging studies, and the history of seizures in patients with MPS II. Therefore, we decided to search this association. We included 9 patients with MPS II and performed imaging studies of the brain to detect the presence of cortico-subcortical atrophy, enlarged subarachnoid space and supratentorial ventricular size. Additionally, we performed EEG studies in sleep and awake conditions and a complete clinical description. Five out of the nine patients presented history of seizures and all except one patient (88.9%) presented some CNS structural alteration in the imaging studies, being the most frequent the cortico-subcortical atrophy (77.8%). The EEG results showed low amplitude in all patients and low voltage in sleep condition in eight patients with interhemispheric asymmetry in six patients during awake and sleep conditions. Although the five patients with history of seizures did not present a distinctive EEG anomaly, four of them presented some structural alteration in the imaging studies. In conclusion, most patients presented structural alterations in the CNS; likewise, all of them presented EEG anomalies mainly during sleep conditions. However, a clear association between EEG, CNS and the history of seizures was not established.

Indexed as

AdolescentBrainChildChild, PreschoolElectroencephalographyHumansMagnetic Resonance ImagingMaleMucopolysaccharidosis IISeizuresElectroencephalogramHunter syndromeMagnetic resonance imagingMucopolysaccharidosis type II

Identifiers

PMID27913904
OpenAlexW2557930432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.